Azra AI Acquires Thynk Health to Close the Gap Between Imaging and Cancer Care
Azra AI, the leading end-to-end enterprise platform for incidental findings and oncology workflow automation, today announced the acquisition of Thynk Health, the specialized leader of lung cancer screening and incidental findings management. The deal unites two of healthcare's most trusted names in imaging-driven care coordination, with a shared goal: ensuring that no patient falls through the cracks between detection, diagnosis, and treatment.
The combined Azra AI and Thynk Health platforms are already deployed across hundreds of hospitals and represent the largest install base in its market segment, including five of the top ten healthcare systems in the United States. Currently processing well over half a billion clinical reports and messages annually in real time — at the scale and reliability that health systems can trust — the combination of these two platforms further strengthens their leadership position, which translates directly into fewer missed findings, faster follow-up, and stronger patient retention across the enterprise.